ROYDEN COE

Royden Coe

Director Pharmaceuticals

Scientist with more than 25 years experience in the development and optimization of formulation, process, and product development of parenteral and solid dosage forms. Roy has worked with a range of formulation technologies; including, but not limited to sterile dosage forms; solution, liposomal, lyophilized, and solid dosage forms; hot melt hard gelatin capsules. He has extensive experience in the design (design of experiments and response surface modeling) and execution of experiments for process development, optimization, and process scale up. He has performed technical transfer from the lab to GMP manufacturing and process scale up studies on over 20 products, many of which later received market approval. Roy has been responsible for ensuring cGMP compliance for finished dosage for the manufacture of clinical batches. Roy has been employed by Cardiokine, Inc., Discovery Laboratories, Inc., Élan Pharmaceuticals, The Liposome Company, Steris Laboratories, and Elkins-Sinn, Inc.

//back to bios//